BridgeMD
New treatment option for Liver Transplant; Complications
Official title Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial)
ClinicalTrials.gov ID: NCT07169643
What this study is testing
What is Darbepoetin (DP)?
Darbepoetin (DP) is an investigational medicine, given as a monthly injection under the skin, being studied as a potential treatment for liver transplant; complications.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a national multicenter, randomized clinical trial to evaluate the the efficacy and safety of DP administration in patients on the liver transplant waiting list to reduce intraoperative red blood cell concentrate transfusion.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Age ≥ 18 years old
- Patients on the official liver transplant waiting list
- Hemoglobin (Hb) level ≤ 11.5 g/dL
- Women of child-bearing potential\ must have a negative pregnancy test in serum before the inclusion in the study and agree to use highly effective...
- A woman will be considered of childbearing potential, following menarche and until becoming post-menopausal unless permanently sterile. Permanent...
You likely can't join if
- 1\. Acute/subacute liver failure (see appendix 7) 2. Patients with acute-on-chronic liver failure grade III and/or MELD \> 35 3. History of...
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Catalonia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Catalonia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.